Fidelity Adv Biotech-IFBTIX
13F holders, Q3 2025 (September 30)2holders
2new positions
0sold out
$36.49avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Fidelity Adv Biotech-I (FBTIX) in their 13F filings, unchanged from Q1 2025. 2 opened new positions and 0 sold out. The largest holders were Sequent Asset Management, LLC ($719K) and Vermillion Wealth Management, Inc. ($36K).
- Company
- Fidelity Adv Biotech-I
- CUSIP
- 315918466
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $755K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q3 2025: 20,679 shares bought, net +20,679 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Sequent Asset Management, LLC | 0.34% | New | 19,698 | $719K |
| Vermillion Wealth Management, Inc. | 0.01% | New | 981 | $36K |
"% of holder's portfolio" is FBTIX's weight in each manager's 13F, not the share of Fidelity Adv Biotech-I the manager owns.